OSTEOSARCOMA RECURRENT
Clinical trials for OSTEOSARCOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA RECURRENT trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo offers hope for kids with tough cancers
Disease control Recruiting nowThis study is testing a new combination of two oral drugs, AMXT 1501 and eflornithine (DFMO), for children and young adults with certain hard-to-treat cancers that have come back or not responded to standard treatments. The first part of the study aims to find the safest and most…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Apr 04, 2026 03:06 UTC
-
New drug combo tested for tough bone cancer in kids and adults
Disease control Recruiting nowThis early-stage study is testing a new drug called tegavivint, given with the chemotherapy gemcitabine, for people whose bone cancer (osteosarcoma) has come back or hasn't responded to standard treatments. The main goal is to find the highest safe dose of this combination. Resea…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC